SCHEMBL509000

SCHEMBL509000

CCOC(=O)/C(C)=N\N(C)C(=O)Cc1c(CC)cc(Cl)cc1CC

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.39
MAPT P10636 7/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
GAA P10253 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GPR35 Q9HC97 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPK1 P28482 2/20 0.32
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31
HPGD P15428 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL509001 1.00 ABCB1 (0.39) ABCB1MAPTL3MBTL1GAASMN1; SMN2
SCHEMBL919585 0.94 ABCB1 (0.42) ABCB1MAPTL3MBTL1GAASMN1; SMN2
SCHEMBL510087 0.91 MAPT (0.36) ABCB1MAPTGAAKDM4EMEN1
SCHEMBL466427 0.91 MAPT (0.36) ABCB1MAPTGAAKDM4EMEN1
SCHEMBL15341149 0.90 MAPT (0.35) ABCB1MAPTGAAALDH1A1MAPK1
SCHEMBL3785204 0.88 ABCB1 (0.43) ABCB1MAPTL3MBTL1GAASMN1; SMN2
SCHEMBL15341148 0.85 MAPT (0.33) ABCB1MAPTL3MBTL1SMN1; SMN2MEN1
SCHEMBL1782878 0.82 LMNA (0.32) ABCB1GAA
SCHEMBL15341147 0.81 MAPT (0.36) ABCB1MAPTL3MBTL1GAASMN1; SMN2
SCHEMBL15341154 0.81 MAPT (0.38) ABCB1MAPTL3MBTL1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507410-B2 Pyridazinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-08-13 US disclosed
US-8470738-B2 Pyridazinone compound and herbicide containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-06-25 US disclosed
US-20120028803-A1 PYRIDAZINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-02 US disclosed
EP-2188264-B1 PYRIDAZINONE COMPOUND AND HERBICIDE CONTAINING THE SAME SUMITOMO CHEMICAL CO (JP) 2011-03-23 EP disclosed
US-20100216642-A1 PYRIDAZINONE COMPOUND AND HERBICIDE CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028803-A1 PYRIDAZINONE COMPOUND AND USE THEREOF C5, C1S, WEE1 ABCB1 4546/4885MAPT 4297/4885L3MBTL1 687/4885
US-20100216642-A1 PYRIDAZINONE COMPOUND AND HERBICIDE CONTAINING THE SAME WEE1, WEE2, CBR3 ABCB1 2150/4885MAPT 4247/4885L3MBTL1 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.